Evidence map›Paper›PMID 30864748›Full record

Trial reportJournal of clinical hypertension (Greenwich, Conn.)2019

Sustained blood pressure control and coronary heart disease, stroke, heart failure, and mortality: An observational analysis of ALLHAT.

C Barrett Bowling, Barry R Davis, Alison Luciano, Lara M Simpson, Richard Sloane, Carl F Pieper, Paula T Einhorn, Suzanne Oparil, Paul Muntner

Open access · bronzeAbstract readMulticenter StudyObservational StudyRandomized Controlled Trial
In one paragraph

Trial report in Journal of clinical hypertension (Greenwich, Conn.), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it, 20 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Observational
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

C Barrett BowlingDurham Veterans Affairs Geriatric Research Education and Clinical Center, Durham Veterans Affairs Medical Center (VAMC), Durham, North Carolina.ORCID 0000-0001-6265-8623
Barry R DavisThe University of Texas School of Public Health, Houston, Texas.
Alison LucianoCenter for Study of Aging and Human Development, Duke University, Durham, North Carolina.
Lara M SimpsonThe University of Texas School of Public Health, Houston, Texas.
Richard SloaneCenter for Study of Aging and Human Development, Duke University, Durham, North Carolina.
Carl F PieperCenter for Study of Aging and Human Development, Duke University, Durham, North Carolina.
Paula T EinhornDivision of Cardiovascular Sciences, National Heart, Lung, and Blood Institute of the National Institutes of Health, Bethesda, Maryland.
Suzanne OparilDepartment of Medicine, University of Alabama at Birmingham, Birmingham, Alabama.
Paul MuntnerDepartment of Epidemiology, University of Alabama at Birmingham, Birmingham, Alabama.
Duke University · USThe University of Texas Health Science Center at Houston · USUniversity of Alabama at Birmingham · USNational Institutes of Health · US

Funding

Sustained blood pressure control and progression of multimorbidityR01HL133618 · NHLBI · EMORY UNIVERSITY · PI BOWLING, CHRISTOPHER BARRETT · 2016 to 2019
$2.0M
NHLBI NIH HHS R01 HL133618
6 · The paper itself

Abstract

Achieving blood pressure (BP) control is associated with lower cardiovascular disease (CVD) risk, but less is known about CVD risk associated with sustained BP control over time. This observational analysis of the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) was restricted to participants with four to seven visits with systolic BP (SBP) measurements during a 22-month period (n = 24 309). The authors categorized participants as having sustained BP control (SBP < 140 mm Hg) at 100%, 75% to <100%, 50% to <75%, and <50% of visits during this period. Outcomes included fatal coronary heart disease (CHD)/nonfatal myocardial infarction (MI), stroke, heart failure (HF), a composite CVD outcome (fatal CHD/nonfatal MI, stroke, or HF), and mortality. Hazard ratios (HRs) for the association of category of sustained BP control for each outcome were obtained using proportional hazards models. SBP control was present among 20.0% of participants at 100%, 16.4% at 75% to less than 100%, 27.0% at 50% to less than 75%, and 36.6% at less than 50% of visits. Compared to those with SBP control at 100% visits, adjusted HR (95% CI) among those with SBP control at <50% of visits was 1.16 (0.93-1.44) for fatal CHD/nonfatal MI, 1.71 (1.26-2.32) for stroke, 1.63 (1.30-2.06) for HF, 1.39 (1.20-1.62) for the composite CVD outcome, and 1.14 (0.99-1.30) for mortality. Sustained SBP control may be beneficial for preventing stroke, HF, and CVD outcomes in adults taking antihypertensive medication.

Indexed as

AgedAntihypertensive AgentsBlood PressureBlood Pressure DeterminationCase-Control StudiesCoronary DiseaseFemaleHeart FailureHumansHypertensionHypolipidemic AgentsIncidenceMaleMiddle AgedMyocardial InfarctionOutcome Assessment, Health CareAntihypertensive AgentsHypolipidemic Agentsblood pressure controlhypertensionsystolic blood pressure

Identifiers

PMID30864748
PMCPMC6532783
OpenAlexW2921037957

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.